Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
J Gen Intern Med
.
2022 Nov;37(14):3758-3761.
doi: 10.1007/s11606-022-07633-y.
Epub 2022 Apr 29.
Authors
Sadiq Y Patel
1
,
Esteban G Ortiz
1
2
,
Benjamin A Barsky
3
,
Haiden A Huskamp
1
,
Alisa B Busch
1
4
,
Ateev Mehrotra
5
6
7
Affiliations
1
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
2
NIDA Summer Research Intern, Washington University in St. Louis, St. Louis, MO, USA.
3
Interfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, USA.
4
McLean Hospital, Belmont, MA, USA.
5
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. mehrotra@hcp.med.harvard.edu.
6
Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA. mehrotra@hcp.med.harvard.edu.
7
OptumLabs Visiting Fellow, Eden Prairie, MN, USA. mehrotra@hcp.med.harvard.edu.
PMID:
35488099
PMCID:
PMC9054110
DOI:
10.1007/s11606-022-07633-y
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Aged
Buprenorphine* / therapeutic use
Humans
Medicare
Telemedicine*
United States
Substances
Buprenorphine
Grants and funding
P30 DA035772/DA/NIDA NIH HHS/United States
R01 DA048533/DA/NIDA NIH HHS/United States
T32 MH019733/MH/NIMH NIH HHS/United States
R01 DA04853303/DA/NIDA NIH HHS/United States